Literature DB >> 28660236

Expression, Purification and Crystallisation of the Adenosine A2A Receptor Bound to an Engineered Mini G Protein.

Byron Carpenter1, Christopher G Tate1.   

Abstract

G protein-coupled receptors (GPCRs) promote cytoplasmic signalling by activating heterotrimeric G proteins in response to extracellular stimuli such as light, hormones and nucleosides. Structure determination of GPCR-G protein complexes is central to understanding the precise mechanism of signal transduction. However, these complexes are challenging targets for structural studies due to their conformationally dynamic and inherently transient nature. We recently developed an engineered G protein, mini-Gs, which addressed these problems and allowed the formation of a stable GPCR-G protein complex. Mini-Gs facilitated the structure determination of the human adenosine A2A receptor (A2AR) in its G protein-bound conformation at 3.4 Å resolution. Here, we describe a step by step protocol for the expression and purification of A2AR, and crystallisation of the A2AR-mini-Gs complex.

Entities:  

Keywords:  A2AR; Active state; Adenosine A2A receptor; G protein complex; G protein-coupled receptor; GPCR; Mini G protein; Mini-Gs

Year:  2017        PMID: 28660236      PMCID: PMC5484405          DOI: 10.21769/BioProtoc.2234

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  6 in total

1.  A rapid, sensitive, and specific method for the determination of protein in dilute solution.

Authors:  W Schaffner; C Weissmann
Journal:  Anal Biochem       Date:  1973-12       Impact factor: 3.365

2.  Expression and Purification of Mini G Proteins from Escherichia coli.

Authors:  Byron Carpenter; Christopher G Tate
Journal:  Bio Protoc       Date:  2017-04-20

3.  Thermostabilisation of an agonist-bound conformation of the human adenosine A(2A) receptor.

Authors:  Guillaume Lebon; Kirstie Bennett; Ali Jazayeri; Christopher G Tate
Journal:  J Mol Biol       Date:  2011-04-09       Impact factor: 5.469

4.  Structure of the adenosine A(2A) receptor bound to an engineered G protein.

Authors:  Byron Carpenter; Rony Nehmé; Tony Warne; Andrew G W Leslie; Christopher G Tate
Journal:  Nature       Date:  2016-07-27       Impact factor: 49.962

5.  Purification and Crystallization of a Thermostabilized Agonist-Bound Conformation of the Human Adenosine A(2A) Receptor.

Authors:  Christopher G Tate; Guillaume Lebon
Journal:  Methods Mol Biol       Date:  2015

6.  Engineering a minimal G protein to facilitate crystallisation of G protein-coupled receptors in their active conformation.

Authors:  Byron Carpenter; Christopher G Tate
Journal:  Protein Eng Des Sel       Date:  2016-09-26       Impact factor: 1.650

  6 in total
  5 in total

1.  Expression and Purification of Mini G Proteins from Escherichia coli.

Authors:  Byron Carpenter; Christopher G Tate
Journal:  Bio Protoc       Date:  2017-04-20

2.  Molecular basis of β-arrestin coupling to formoterol-bound β1-adrenoceptor.

Authors:  Yang Lee; Tony Warne; Rony Nehmé; Shubhi Pandey; Hemlata Dwivedi-Agnihotri; Madhu Chaturvedi; Patricia C Edwards; Javier García-Nafría; Andrew G W Leslie; Arun K Shukla; Christopher G Tate
Journal:  Nature       Date:  2020-06-17       Impact factor: 49.962

Review 3.  Human Adenosine A2A Receptor: Molecular Mechanism of Ligand Binding and Activation.

Authors:  Byron Carpenter; Guillaume Lebon
Journal:  Front Pharmacol       Date:  2017-12-14       Impact factor: 5.810

4.  Cryo-EM structure of the adenosine A2A receptor coupled to an engineered heterotrimeric G protein.

Authors:  Javier García-Nafría; Yang Lee; Xiaochen Bai; Byron Carpenter; Christopher G Tate
Journal:  Elife       Date:  2018-05-04       Impact factor: 8.140

5.  Structural insight into small molecule action on Frizzleds.

Authors:  Paweł Kozielewicz; Ainoleena Turku; Carl-Fredrik Bowin; Julian Petersen; Jana Valnohova; Maria Consuelo Alonso Cañizal; Yuki Ono; Asuka Inoue; Carsten Hoffmann; Gunnar Schulte
Journal:  Nat Commun       Date:  2020-01-21       Impact factor: 14.919

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.